Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
GlobalData has estimated that GLP-1 receptor agonist sales for the type 2 diabetes and obesity markets will reach more than US$125 billion in 2033
Consistency with the medication and lifestyle changes is the key to seeing results
"No one told me it was meant to be a lifelong medication
The 1,400-patient STEP UP trial found an average weight loss of 21% with Wegovy 7.2 mg, with more than a quarter (27%) of people treated with that dose falling into the early responder category, and discontinuation rates due to side effects were at the same level as the 2.4 mg dose
US$ 23.06
US$ 24.92
US$ 22.93
US$ 23.32
US$ 28.15
US$ 22.25
US$ 20.63
US$ 20.96
